Metopirone - Metyrapone 250 mg / 1 Capsule 18 Capsule, Gelatin Coated

Reference details for licensed healthcare facility review and verification.

Metyrapone NDC Family 76336-0455 Metyrapone 250 mg / 1

NDC 11	76336-0455-18
Product NDC	76336-0455
Generic Drug Name	Metyrapone
Brand Name	Metopirone
Manufacturer	HRA Pharma Rare Diseases
Strength	250 mg / 1
Dosage Form	Capsule
Drug Type	Oral
Package Quantity	18 Capsule, Gelatin Coated
Package Description	18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18)
Active Ingredients	Metyrapone
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Metyrapone 250 mg / 1 Capsule is tracked under NDC 76336-0455-18 and rolls up into product family 76336-0455. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 18 Capsule, Gelatin Coated.
Manufacturer: HRA Pharma Rare Diseases.
Dosage form: Capsule.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubMetyrapone 250 mg / 1 Capsule 18 Capsule, Gelatin Coated Bottle2 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Metopirone - Metyrapone 250 mg / 1 Capsule 18 Capsule, Gelatin CoatedNDC 68118-0455-18 | 18 Capsule, Gelatin Coated | Esteve Pharmaceuticals, S.A.

Metopirone - Metyrapone 250 mg / 1 Capsule 18 Capsule, Gelatin Coated, NDC 76336-0455-18, is a HRA Pharma Rare Diseases 250 mg / 1 capsule presentation packaged as 18 Capsule, Gelatin Coated.

NDC search formats

Canonical NDC 11: 76336-0455-18
Digits-only NDC 11: 76336045518
Possible 10-digit display format: 76336-455-18 (7633645518)

Helpful product links

Search by brand name: Metopirone
NDC 11: 76336-0455-18
Product family NDC: 76336-0455
VA classification code: DX900
VA classification code description: DIAGNOSTICS,OTHER
CMOP ID: M0456
VUID: 4013674